F. Sablier-Gallis

Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics

H. Goossens, Mohamed Mysara, M. Bonten, 2021, Nature Communications.

Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection

J. de Gunzburg, A. Andremont, P. Hugon, 2018, Antimicrobial Agents and Chemotherapy.

Impact of oral amoxicillin and amoxicillin/clavulanic acid treatment on bacterial diversity and β-lactam resistance in the canine faecal microbiota.

J. de Gunzburg, L. Guardabassi, P. Hugon, 2019, The Journal of antimicrobial chemotherapy.

Microbiota-based markers predictive of development of Clostridioides difficile infection

H. Goossens, Mohamed Mysara, M. Bonten, 2021, Nature Communications.

Protection of the Human Gut Microbiome From Antibiotics

E. Le Chatelier, S. Kennedy, F. Levenez, 2017, bioRxiv.

PREVENTION OF ANTIBIOTIC-INDUCED DYSBIOSIS IN HUMAN VOLUNTEERS BY DAV132 AND PRESERVATION OF RESPONSIVENESS TO ANTI-PD-1 THERAPY DEMONSTRATED BY TRANSPLANTATION OF HUMAN FECES INTO TUMOR-BEARING MICE

A. Andremont, N. Saint-Lu, J. Gunzburg, 2022 .

Optimization of an Assay To Determine Colonization Resistance to Clostridioides difficile in Fecal Samples from Healthy Subjects and Those Treated with Antibiotics

J. de Gunzburg, M. Wilcox, A. Andremont, 2020, Antimicrobial Agents and Chemotherapy.